Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
12/16/2024 | $100.00 → $115.00 | Neutral → Buy | BofA Securities |
12/16/2024 | $113.00 | Mkt Outperform | JMP Securities |
10/7/2024 | $114.00 → $90.00 | Buy → Neutral | BofA Securities |
9/22/2023 | $108.00 | Overweight | JP Morgan |
6/30/2023 | $138.00 | Buy | BofA Securities |
12/14/2021 | $120.00 | Market Perform → Market Outperform | CJS Securities |
8/6/2021 | $130.00 → $139.00 | Outperform | Barrington Research |
EAGAN, Minn., June 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ:POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and enable drug development, today announced the appointment of Dr. Bernard A. Harris, Jr. to its newly-formed Business Advisory Board (BAB). "I am very pleased to welcome Dr. Harris to our new Business Advisory Board," said Raymond F. Vennare, Chief Executive Officer of Predictive Oncology. "As we continue
~Highly Esteemed Growth Strategist and Financial Expert with Decades of Business Acumen~ NEW YORK, Oct. 18, 2022 /PRNewswire/ -- The National Kidney Foundation (NKF) is pleased to announce the appointment of Anne Motsenbocker to its national Board of Directors. We're honored & excited Anne has joined the national board to share her extensive business acumen in board governance.Motsenbocker resides in Dallas, Texas and is a former banker and seasoned board member bringing over 35 years of commercial banking and wealth management expertise due to the numerous roles she held at J
HOUSTON, June 10, 2022 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled healthcare services company comprised of a hospital division with 21 facilities in 8 states and a primary care-centric, risk-bearing population health management division, today announced the appointment of Jon Bates as the Company's Chief Financial Officer effective on or about June 30, 2022. On May 3, 2022, Michael Bowen notified the company that he intends to retire as Chief Financial Officer of the Company. In connection with Mr. Bowen's retirement, the Company's Board formed a search committee. On June 8, 2022, the Company announced the appointme
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
10-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
U.S. Physical Therapy, Inc. (the Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of a physical therapy practice with three clinic locations in Wyoming, which currently generates approximately $4.3 million in annual revenues and 23,000 in annual visits. The Company acquired a 65% interest in the acquired company with the current owners retaining a 35% ownership interest. Graham Reeve, Chief Operating Officer-West, said, "We are excited to welcome our newest partners into our USPH family and expand our service offerings in the state of Wyoming. This team has developed incredibl
Reports Record Quarterly Patient Volume Company Provides 2025 Earnings Guidance U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the three months and year ended December 31, 2024. FINANCIAL HIGHLIGHTS Year Ended December 31, 2024 versus Year Ended December 31, 2023 Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles ("GAAP") measure, was $81.8 million for the year ended December 31, 2024 ("2024 Year"), an increase of $3.9 million, from $77.9 million for the year ended December 31, 2023 ("2023 Year"). Oper
U.S. Physical Therapy, Inc. (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the fourth quarter and year ended December 31, 2024, on Wednesday, February 26, 2025, after the stock market closes, with the conference call to follow the next morning, on Thursday, February 27, 2025. Conference Call Date: Thursday, February 27, 2025 Time: 10:30 am Eastern/9:30 am Central Dial-In Number: (800) 445-7795 Primary or (785) 424-1699 Alternate Conference ID: USPHQ424 (In order to join this conference call, you will be required to prov
U.S. Physical Therapy, Inc. (the Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of a physical therapy practice with three clinic locations in Wyoming, which currently generates approximately $4.3 million in annual revenues and 23,000 in annual visits. The Company acquired a 65% interest in the acquired company with the current owners retaining a 35% ownership interest. Graham Reeve, Chief Operating Officer-West, said, "We are excited to welcome our newest partners into our USPH family and expand our service offerings in the state of Wyoming. This team has developed incredibl
U.S. Physical Therapy, Inc. (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the fourth quarter and year ended December 31, 2024, on Wednesday, February 26, 2025, after the stock market closes, with the conference call to follow the next morning, on Thursday, February 27, 2025. Conference Call Date: Thursday, February 27, 2025 Time: 10:30 am Eastern/9:30 am Central Dial-In Number: (800) 445-7795 Primary or (785) 424-1699 Alternate Conference ID: USPHQ424 (In order to join this conference call, you will be required to prov
U.S. Physical Therapy, Inc. (the Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of a hand and physical therapy practice with eight clinic locations in Wyoming which currently generates approximately $6.5 million in annual revenues and 43,000 in annual visits. The Company acquired a 75% interest in the Company with the current owners retaining a 25% ownership interest. Chris Reading, Chief Executive Officer, said, "We are excited to welcome our newest partners into our USPH family. The founders have forged a tremendous asset for patients in their communities. On behalf of our
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
BofA Securities upgraded U.S. Physical Therapy from Neutral to Buy and set a new price target of $115.00 from $100.00 previously
JMP Securities initiated coverage of U.S. Physical Therapy with a rating of Mkt Outperform and set a new price target of $113.00
BofA Securities downgraded U.S. Physical Therapy from Buy to Neutral and set a new price target of $90.00 from $114.00 previously
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)